Stockist or custom formulator?
The first fork. Stockist means you pick from a manufacturer's library of proven, already-stable formulations, swap in your label, and ship. Custom means R&D drafts a formula to your spec, prototypes it, runs stability, and only then enters production. The mistake most first-time founders make is assuming custom is the prestige path. It rarely is.
Stock formulations carry the weight of 6 to 18 months of prior stability data, batch history, and supply continuity. Your time-to-market drops from 12-16 weeks (custom) to 4-6 weeks (stock). Your MOQ floor drops by about half. Your cost per unit drops because raw materials are bought in consolidated runs, not bespoke ones. Almost every emerging vitamin brand that scales past $1M in year one launched on stock and reformulated later.
Custom earns its premium in only three scenarios: (a) you have a clinical positioning the stock library cannot match (e.g. methylated B-complex at a specific microgram dose, prenatal with non-standard choline plus DHA), (b) you need a proprietary trademark on the blend to defend a price point, or (c) you have distribution committed at a volume where the per-unit savings of bespoke sourcing outweigh the R&D amortisation.
Then: Stockist. Pick from a library, launch in 4-6 weeks.
Then: Custom. Budget 12-16 weeks plus $4k-$12k R&D
Then: Custom is defensible on per-unit math alone

